1456 – The neurotoxicity of amphetamines during the adolescent period.
1455 – Strategies for Successfully Teaching Students with ADD or ADHD in Instrumental Lessons
1454 – Reward modulation of cognitive function in adult attention-deficit/hyperactivity disorder: a pilot study on the role of striatal dopamine.
1453 – Neuropsychological performance of youth with secondary attention-deficit/hyperactivity disorder 6- and 12-months after traumatic brain injury.
1452 – Long-Term Efficacy of Methylphenidate Immediate-Release for the Treatment of Childhood ADHD – A Systematic Review and Meta-Analysis
1451 – Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells.
1450 – [A case of large arteriovenous malformation in the frontal lobe complicating attention-deficit/hyperactivity disorder].
1449 – A Preliminary Near-Infrared Spectroscopy Study in Adolescent and Adult Patients with Attention-Deficit/Hyperactivity Disorder Symptoms
1448 – A Review on Atomoxetine in the Treatment of ADHD
1447 – A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorder.
1446 – Acute and Sustained Effects of Methylphenidate on Cognition and Presynaptic Dopamine Metabolism: An [18F]FDOPA PET Study.
1445 – Adult ADHD vs. Bipolar Disorder in the DSM-5 Era: A Challenging Differentiation for Clinicians.
1444 – Asthma in patients with attention-deficit/hyperactivity disorder: A nationwide population-based study.
1443 – Attention deficit/hyperactivity disorder and medication with stimulants in young children: A DTI study
1442 – Attention skills and executive functioning in children with Noonan syndrome and their unaffected siblings.
1441 – Attention-deficit hyperactivity disorder (ADHD), substance use disorders, and criminality: a difficult problem with complex solutions.
1440 – Autistic spectrum disorder, attention deficit hyperactivity disorder, and psychiatric comorbidities: A nationwide study
1439 – Bullying Victimization and Perpetration and Their Correlates in Adolescents Clinically Diagnosed With ADHD
1438 – Carer perspective on treatment, comorbidities and diagnosis of Paediatric ADHD in France
1437 – Computerised assistance for ADHD testing is to be welcomed.
1436 – Detection and Delineation of Attention Deficit Hyperactivity Disorder Using a Mathematical Model
1435 – Diagnosis and Management of ADHD in Children.
1434 – Differential motor alterations in children with three types of attention deficit hyperactivity disorder.
1433 – Early Detection of Autism Spectrum Disorders in Children With Attention Deficit Hyperactivity Disorder by Modified Checklist for Autism in Toddlers: a Pilot Study From India
1432 – Early Detection of Autism Spectrum Disorders in Children With Attention Deficit Hyperactivity Disorder by Modified Checklist for Autism in Toddlers: a Pilot Study From India
1431 – Effects of Korean Red Ginseng Extract on Behavior in Children with Symptoms of Inattention and Hyperactivity/Impulsivity: A Double-Blind Randomized Placebo-Controlled Trial
1430 – Effects of shift work on attention deficit, hyperactivity, and impulsivity, and their relationship with chronotype
1429 – Factors related with unintentional injuries in children with newly diagnosed attention-deficit/hyperactivity disorder.
1428 – False Memory in Adults With ADHD – A Comparison Between Subtypes and Normal Controls
1427 – Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder.
1426 – Improving patient care for attention deficit hyperactivity disorder in children by organizational redesign (Tornado program) and enhanced collaboration between psychiatry and general practice: a controlled before and after study.
1425 – Increased prefrontal hemodynamic change after atomoxetine administration in pediatric attention-deficit/hyperactivity disorder as measured by near-infrared spectroscopy.
1424 – Assessing ADHD symptomatic behaviors and functional impairment in school settings: Impact of student and teacher characteristics.
1423 – Assessing, understanding, and supporting students with ADHD at school: Contemporary science, practice, and policy.
1422 – Atopy in attention deficit hyperactivity disorder (ADHD) pediatric patients in South Jordan
1421 – Autobiographical memory in ADHD subtypes
1420 – Differential effects of Theta/Beta and SMR neurofeedback in ADHD on sleep onset latency
1419 – Electrodermal Responding Predicts Responses to, and May Be Altered by, Preschool Intervention for ADHD.
1418 – Evaluating the content of Individualized Education Programs and 504 Plans of young adolescents with attention deficit/hyperactivity disorder.
1417 – Event rate and reaction time performance in ADHD: Testing predictions from the state regulation deficit hypothesis using an ex-Gaussian model.
1416 – Interactions between MAOA and SYP polymorphisms were associated with symptoms of attention-deficit/hyperactivity disorder in Chinese Han subjects.
1415 – Knowledge of and Attitude towards Attention-deficit Hyperactivity Disorder among Primary School Teachers in Jordan
1414 – Is Maternal Smoking During Pregnancy a Risk Factor for Cigarette Smoking in Offspring? A Longitudinal Controlled Study of ADHD Children Grown Up
1413 – Maternal Depression History Moderates Parenting Responses to Compliant and Noncompliant Behaviors of Children with ADHD.
1412 – Maternal smoking and offspring inattention and hyperactivity: results from a cross-national European survey
1411 – Microstructural abnormalities in the combined and inattentive subtypes of attention deficit hyperactivity disorder: a diffusion tensor imaging study.
1410 – Neurophysiological Biomarkers Informing Architecture And Design: A Comparative Analysis Of Neural And Behavioral Data For Adhd Populations
1409 – Normalisation of frontal theta activity following methylphenidate treatment in adult attention-deficit/hyperactivity disorder
1408 – Parent- and Teacher-Reported Symptoms of ADHD in School-Aged Children With Active Epilepsy – A Population-Based Study
1407 – Parenting Mediates Symptoms and Impairment in Children With ADHD-Inattentive Type.
1406 – Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia.
1405 – Peer Preference and Friendship Quantity in Children with Externalizing Behavior: Distinct Influences on Bully Status and Victim Status.
1404 – Prevalence of adult attention deficit hyperactivity disorder and its correlates among recently diagnosed young adult males with HIV.
1403 – Prevalence of Voiding Dysfunction and Constipation in Children with Attention Deficit Hyperactivity Disorder
1402 – Probabilistic reward learning in adults with attention deficit hyperactivity disorder –an electrophysiological study
1401 – Reconstituting the ADHD girl: accomplishing exclusion and solidifying a biomedical identity in an ADHD class
1400 – Role of ADHD Symptoms as a Contributing Factor to Obesity in Patients with MC4R Mutations
1399 – Role of Transcranial magnetic stimulation (TMS & rTMS) in investigation and possible treatment of Impulsivity in neuropsychiatric disorders with ADHD and BPD as examples.
1398 – State, trait anxiety and selective attention differences in Attention Deficit Hyperactivity Disorder (ADHD) subtypes
1397 – Suicide Ideation and Attempts in Children With Psychiatric Disorders and Typical Development.
1396 – The familial and other environmental risk factors in children with attention deficit hyperactivity disorder.
1395 – The Potential Influence of Obstructive Airways and The Diagnosis of ADHD in Children
1394 – [The results of the pharmacological treatment of attention deficit hyperactivity disorder: evaluation with neuropsychological methods.]
1393 – Variability in ADHD Care in Community-Based Pediatrics.
1392 – Yoga and the Therapy of Children with Attention Deficit Hyperactivity Disorder
1391 – Unmet Needs Associated with Attention-Deficit/Hyperactivity Disorder in Eight European Countries as Reported by Caregivers and Adolescents: Results from Qualitative Research.
1390 – Understanding ADHD from a Biopsychosocial-Cultural Framework: A Case Study
1389 – Treatment Receipt and Outcomes from a Clinic Employing the Attention-Deficit/Hyperactivity Disorder Treatment Guideline of the Children’s Medication Algorithm Project
1388 – Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Irritability: Results From the Multimodal Treatment Study of Children With ADHD (MTA)
1387 – The Norepinephrine Transporter in Attention-Deficit/Hyperactivity Disorder Investigated With Positron Emission Tomography
1386 – The Co-occurrence of Attention-Deficit/Hyperactivity Disorder and Unipolar Depression in Children and Adolescents: A Meta-Analytic Review
1385 – TEACHER-TO-TEACHER CONSULTATION: FACILITATING CONSISTENT AND EFFECTIVE INTERVENTION ACROSS GRADE LEVELS FOR STUDENTS WITH ADHD
1384 – Task-Related Electroencephalographic Deviances in Adults with Attention Deficit Hyperactivity Disorder.
1383 – State and trait anxiety level and severity of depression among mothers of children with attention deficit hyperactivity disorder and conduct disorder. Pilot study
1382 – State and trait anxiety level and increase of depression among mothers of children with attention deficit hyperactivity disorder and conduct disorder. pilot study.
1381 – Sleep and ADHD: what we know and what we don’t know
1380 – Self-Monitoring by College Students With ADHD – The Impact on Academic Performance
1379 – Research Review: Birth by caesarean section and development of autism spectrum disorder and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.
1378 – PS-253b Gluten Free Diet For Children With Attention Deficit And Hyperactivity Disorder
1377 – Proprioceptive diagnostics in attention deficit hyperactivity disorder.
1376 – Prevalence of incontinence, attention deficit/hyperactivity disorder and oppositional defiant disorder in preschool children
1375 – Power Struggle, Submission and Partnership: Agency Constructions of Mothers of Children with ADHD Diagnosis in Their Narrated School Involvement
1374 – Peer dislike and victimisation in pathways from ADHD symptoms to depression
1373 – One-Year Follow-Up of Guided Self-Help for Parents of Preschool Children With Externalizing Behavior.
1372 – Multi-level biomarker analysis of nitric oxide synthase isoforms in bipolar disorder and adult ADHD.
1371 – Longitudinal Associations Between Internalizing and Externalizing Comorbidities and Functional Outcomes for Children with ADHD.
1370 – Influence of the symptoms of Attention Deficit Hyperactivity Disorder (ADHD) and comorbid disorders on functioning in adulthood.
1369 – Impact of ADHD Symptoms on Clinical and Cognitive Aspects of Problem Gambling
1368 – Factor Structure of Attention Deficit Hyperactivity Disorder Symptoms for Children Age 3 to 5 Years
1367 – Examining Associations Among ADHD, Homework Behavior, and Reading Comprehension: A Twin Study.
1366 – Electroencephalographic Activity Before and After Cognitive Effort in Children With Attention Deficit/Hyperactivity Disorder.
1365 – Efficacy and safety of extended-release guanfacine Hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: A randomized, controlled, phase III trial
1364 – Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder
1363 – Effectiveness and safety of a long-acting, once-daily, two-phase release formulation of methylphenidate (Ritalin® LA) in school children under daily practice conditions.
1362 – Effect of brain structure and function on reward anticipation in children and adults with attention deficit hyperactivity disorder combined subtype (ADHD-CT).
1361 – EEG Neurofeedback treatments in children with ADHD: An updated meta-analysis of Randomized Controlled Trials
1360 – Educating and Supporting Primary Care Providers in the Implementation of Evidence-based Practices for ADHD
1359 – Editorial Perspective: Laying the foundations for next generation models of ADHD neuropsychology.
1358 – Development of Executive Functions in 5- to 12- Years old Iranian Children with and without ADHD
1357 – Dasotraline Adult ADHD Study
1356 – Contingency Management, Quitting Smoking, and ADHD (ADQUIT)
1355 – “Complex” Attention-Deficit Hyperactivity Disorder, More Norm Than Exception? Diagnoses and Comorbidities in a Developmental Clinic.
1354 – Color vision in ADHD: Part 2 – Does Attention influence Color Perception?
1353 – Cognitive Rehabilitation for Attention Deficit/Hyperactivity Disorder (ADHD): Promises and Problems.
1352 – Cognitive impairments are different in single-incidence and multi-incidence ADHD families
1351 – Attention-Deficit/Hyperactivity Disorder in Adults with High-Functioning Pervasive Developmental Disorders in Japan
1350 – Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity
1349 – Alcohol Use Longitudinally Predicts Adjustment and Impairment in College Students With ADHD: The Role of Executive Functions.
1348 – Advances in molecular genetic studies of attention deficit hyperactivity disorder in China.
1347 – ADHD Symptom Levels and Romantic Relationship Quality in College Students.
1346 – A review of attention-deficit/hyperactivity disorder in women and girls: uncovering this hidden diagnosis.
1345 – Validation of the World Health Organization Adult ADHD Self-Report Scale for adolescents.
1344 – The Patient’s Perspective on the Link Between ADHD and Substance Use – A Qualitative Interview Study
1343 – Targeting the Nicotinic Cholinergic System to Treat Attention-Deficit/Hyperactivity Disorder: Rationale and Progress to Date.
1342 – Sleep problems predict comorbid externalizing behaviors and depression in young adolescents with attention-deficit/hyperactivity disorder
1341 – Relationship of Attention Deficit Hyperactivity Disorder and Postconcussion Recovery in Youth Athletes.
1340 – Peer Relationships in Undergraduates With ADHD Symptomatology – Selection and Quality of Friendships
1339 – High IQ May “Mask” the Diagnosis of ADHD by Compensating for Deficits in Executive Functions in Treatment-Naïve Adults With ADHD
1338 – Atomoxetine for treatment of children and adolescents with ADHD.
1337 – A Preliminary Examination of Aerobic Exercise Effects on Resting EEG in Children With ADHD
1335 – Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
1334 – Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature.
1333 – Treatment Outcomes in Anxious Youth with and without Comorbid ADHD in the CAMS.
1332 – Toward Defining the Neural Substrates of ADHD: A Controlled Structural MRI Study in Medication-Naïve Adults
1331 – Tourette-like behaviors in the normal population are associated with hyperactive/impulsive ADHD-like behaviors but do not relate to deficits in conditioned inhibition or response inhibition.
1330 – Time Simulator in Virtual Reality for Children with Attention Deficit Hyperactivity Disorder
1329 – The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD.
1328 – The unmet needs of all adults with ADHD are not the same: a focus on Europe.
1327 – The relationship between childhood history of ADHD symptoms and DSM-IV borderline personality disorder features among personality disordered outpatients: The moderating role of gender and the mediating roles of emotion dysregulation and impulsivity
1326 – The Relationship between Childhood Attention Deficit/Hyperactivity Disorder and Adulthood Borderline Personality Disorder
1325 – The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-Year Follow-Up
1324 – The potential for misuse and abuse of medications in ADHD: a review.
1323 – The Israel Survey of Mental Health among Adolescents Prevalence of Attention-Deficit/Hyperactivity Disorder, Comorbidity, Methylphenidate Use, and Help-Seeking Patterns
1322 – The impending globalization of ADHD: Notes on the expansion and growth of a medicalized disorder
1321 – The Effect of Barkley’s Behavior Management Principles on a child with ADHD in a Lebanese inclusive classroom: A case study
1320 – The Development of Quality Indicators for Management of Patients with ADHD in Social Paediatrics.
1319 – The Association Between Sluggish Cognitive Tempo and Academic Functioning in Youth with Attention-Deficit/Hyperactivity Disorder (ADHD).
1318 – Symptoms of Attention-Deficit Hyperactivity Disorder, Nonsyndromic Orofacial Cleft Children, and Dopamine Polymorphisms: A Pilot Study.
1317 – Structural Validity of the WISC-IV for Students With ADHD
1316 – Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers
1315 – Specific and common genes implicated across major mental disorders: A review of meta-analysis studies.
1314 – Sex differences in ADHD symptom severity.
1313 – Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)
1312 – Response Inhibition and ADHD Traits: Correlates and Heritability in a Community Sample.
1311 – Relationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate.
1310 – Reading Outcomes of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Dyslexia Following Atomoxetine Treatment
1309 – Rates of Effort Test Failure in Children With ADHD: An Exploratory Study.
1308 – Quantitative EEG and Neurofeedback in Children and Adolescents: Anxiety Disorders, Depressive Disorders, Comorbid Addiction and Attention-deficit/Hyperactivity Disorder, and Brain Injury.
1307 – Psychostimulant Prescription for ADHD in New South Wales – A Longitudinal Perspective
1306 – Profile of Sexual and Genitourinary Treatment-Emergent Adverse Events Associated with Atomoxetine Treatment: A Pooled Analysis.
1305 – Preliminary Evaluation of a Combined Group and Individual Treatment for College Students With Attention-Deficit/Hyperactivity Disorder
1304 – Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD).
1303 – Predicting Impairment in College Students With ADHD – The Role of Executive Functions
1302 – PRC-063 in an ADULT Workplace Environment
1301 – Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants.
1300 – Parent training for preschool ADHD: a randomized controlled trial of specialized and generic programs.
1299 – Neuropharmacological effect of atomoxetine on attention network in children with attention deficit hyperactivity disorder during oddball paradigms as assessed using functional near-infrared spectroscopy
1298 – Neurocognitive abilities in the general population and composite genetic risk scores for attention-deficit hyperactivity disorder.
1297 – Negative parenting behavior and childhood oppositional defiant disorder: Differential moderation by positive and negative peer regard.
1296 – Nationwide rate of attention-deficit hyperactivity disorder diagnosis and pharmacotherapy in Korea in 2008–2011
1295 – Multimodal Magnetic Resonance Imaging Study of Treatment-Naïve Adults with Attention-Deficit/Hyperactivity Disorder.
1294 – Minor neurodevelopmental impairments are associated with increased occurrence of ADHD symptoms in children born extremely preterm
1293 – Methylphenidate/fluoxetine interaction
1292 – Mediators of the association between parental severe mental illness and offspring neurodevelopmental problems.
1291 – Manic Symptoms Associated with Isotretinoin and Methylphenidate Combination: a Case Report
1290 – Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.
1289 – Iron, Magnesium, Vitamin D, and Zinc Deficiencies in Children Presenting with Symptoms of Attention-Deficit/Hyperactivity Disorder
1288 – Integrative Couples Group Treatment for Emerging Adults With ADHD Symptoms
1287 – Insights into multimodal imaging classification of ADHD.
1286 – Individual classification of ADHD patients by integrating multiscale neuroimaging markers and advanced pattern recognition techniques.
1285 – Increasing Phenotypic and Genetic variations in Hyperactivity/Inattention Problems from Age 3 to 13 Years: A Cross-Sectional Twin Study.
1284 – Increasing incidence and diagnostic instability in adult attention-deficit hyperactivity disorder nationwide between 1995 and 2012.
1283 – Impact of attention-deficit/hyperactivity disorder on the lives of Italian children and adolescents: data from the European Lifetime Impairment Survey.
1282 – Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
1281 – Higher prevalence of iron deficiency as strong predictor of attention deficit hyperactivity disorder in children
1280 – Geographic Variation in Receipt of Psychotherapy in Children Receiving Attention-Deficit/Hyperactivity Disorder Medications
1279 – Functional status in children with ADHD at age 6-8: a controlled community study.
1278 – fMRI Study of Non-Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
1277 – Factors Related to Self-Reported Attention Deficit Among Incoming University Students
1276 – Extinction learning deficit in a rodent model of attention-deficit hyperactivity disorder.
1275 – Exposure to Air Pollution From Traffic and Neurodevelopmental Disorders in Swedish Twins.
1274 – Exploring parental country of birth differences in the use of psychostimulant medications for ADHD: a whole-population linked data study
1273 – Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD
1272 – Examination of the Effects of Intelligence on the Test of Variables of Attention for Elementary Students
1271 – Everyday Executive Function Impairments Predict Comorbid Psychopathology in Autism Spectrum and Attention Deficit Hyperactivity Disorders.
1270 – Event Rate and Effects of Stimulants in ADHD (ERESA)
1269 – Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs).
1268 – Evaluating the Construct Validity of Adult ADHD and SCT Among College Students – A Multitrait-Multimethod Analysis of Convergent and Discriminant Validity
1267 – Epidemiology of Attention Deficit/ Hyperactive Disorder Among Third Grade Primary School Students of Rasht, 2007- 2008
1266 – Environmental Lead Exposure and Attention-Deficit/Hyperactivity Disorder Symptom Domains in a Community Sample of South Korean School-Age Children.
1265 – Enhanced visual responses in the superior colliculus in an animal model of Attention Deficit Hyperactivity Disorder and their suppression by d-amphetamine.
1264 – Effects of teachers’ internal-external control and leadership type on educational intervention for School-aged Attention Deficit Hyperactivity Disorder.
1263 – Effect of Play Therapy on Visual Memory in ADHD Children
1262 – Effect of Methylphenidate on Height and Weight in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review.
1261 – Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).
1260 – Dysfunctional Modulation of Default Mode Network Activity in Attention-Deficit/Hyperactivity Disorder.
1259 – Dose Response Effects of Quillivant XR in
1258 – Domain-specific and domain-general effects on strategy selection in complex arithmetic: Evidences from ADHD and normally developed college students
1257 – Disparities in Identification of Comorbid Diagnoses in Children With ADHD.
1256 – Disorder-specific grey matter deficits in attention deficit hyperactivity disorder relative to autism spectrum disorder.
1255 – Disorder-dissociated effects of fluoxetine on brain function of working memory in attention deficit hyperactivity disorder and autism spectrum disorder.
1254 – Differential gene body methylation and reduced expression of cell adhesion and neurotransmitter receptor genes in adverse maternal environment.
1253 – Designated
1252 – Culturally Appropriate Assessment of Functional Impairment in Diverse Children – Validation of the ADHD-FX Scale With an At-Risk Community Sample
1251 – Contrasting psychosocial outcomes in Chinese delinquent adolescents with attention deficit and hyperactivity disorder symptoms and/or reading disability
1250 – Continuous performance test in pediatric obsessive-compulsive disorder and tic disorders: the role of sustained attention.
1249 – Comorbidity of ADHD and subsequent bipolar disorder among adolescents and young adults with major depression: a nationwide longitudinal study.
1248 – Comorbidities in Adult Attention-Deficit/Hyperactivity Disorder: a practical guide to diagnosis in primary care.
1247 – Combination and Switching of Stimulants in Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Quebec
1246 – Cognitive variability in adults with ADHD and AS: Disentangling the roles of executive functions and social cognition.
1245 – Cognitive Improvement of Attention and Inhibition in the Late Afternoon in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Treated With Osmotic-Release Oral System Methylphenidate.
1244 – Cognitive Complaints of Adults With Attention Deficit Hyperactivity Disorder
1243 – Cognitive and Adaptive Skill Profile Differences in Children With Attention-Deficit Hyperactivity Disorder With and Without Comorbid Fetal Alcohol Spectrum Disorder.
1241 – Codevelopment of ADHD and externalizing behavior from childhood to adulthood.
1241 – Clinical use of 30:70 controlled-release methylphenidate in the treatment of attention deficit hyperactivity disorder.
1240 – Clinical features and risk factors of co-morbid tic disorder in children with attention deficit hyperactivity disorder.
1239 – Clinical effects of lisdexamfetamine and mixed amphetamine salts immediate release in adult ADHD: results of a crossover design clinical trial.
1238 – Child Routines and Parental Adjustment as Correlates of Internalizing and Externalizing Symptoms in Children Diagnosed with ADHD.
1237 – CHARACTERISTICS OF IN-PATIENTS WITH ADHD AND SUBSTANCE USE DISORDER: A RETROSPECTIVE STUDY
1236 – Central nervous system stimulants for secondary attention deficit-hyperactivity disorder after paediatric traumatic brain injury: a rationale and protocol for single patient (n-of-1) multiple cross-over trials.
1235 – Categorization Behavior in Adults, Adolescents and ADHD-Adolescents: A Comparative Investigation.
1234 – Case-Control Genome-Wide Association Study of Persistent Attention-Deficit Hyperactivity Disorder Identifies FBXO33 as a Novel Susceptibility Gene for the Disorder.
1233 – Bupropion in Adults with Attention-Deficit/Hyperactivity Disorder: a Randomized, Double-blind Study
1232 – Biomarkers in the diagnosis of ADHD – promising directions.
1231 – Behavioral Interventions in Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials across Multiple Outcome Domains
1230 – Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers.
1229 – Attention-deficit/hyperactivity disorder in postsecondary students
1228 – Attention deficit hyperactivitydisorder in children with visualdiseases
1227 – Attention Deficit Hyperactivity Disorder, Other Mental Health Problems, Substance Use, and Driving: Examination of a Population-Based, Representative Canadian Sample.
1226 – Attention deficit and hyperactivity disorder: a therapeutic option.
1225 – Attention characteristics of children with different clinical subtypes of attention deficit hyperactivity disorder.
1224 – Attention benefits after a single dose of metadoxine extended release in adults with predominantly inattentive ADHD.
1223 – Attention-deficit/hyperactivity disorder in childhood/adolescence and impairments associated with daily life: French data from the European Lifetime Impairment Survey.
1221 – Association of SNAP-25, SLC6A2, and LPHN3 With OROS Methylphenidate Treatment Response in Attention-Deficit/Hyperactivity Disorder.
1220 – Association between mobile phone use and inattention in 7102 Chinese adolescents: a population-based cross-sectional study
1219 – Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD.
1218 – Assessment of Cardiovascular Risks due to Methylphenidate in Six Months of Treatment in Children with Attention Deficit and Hyperactivity Disorder
1217 – Application of Computer System Based on Artificial Neural Network and Artificial Intelligence in Diagnosing Child Attention Deficit/Hyperactivity Disorder (AD/HD)
1216 – Aetiological overlap between anxiety and attention deficit hyperactivity symptom dimensions in adolescence.
1215 – Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children.
1214 – ADHD Symptomatology, Fear of Intimacy, and Sexual Anxiety and Behavior Among College Students in China and the United States
1213 – ADHD medication and social self-understanding
1212 – Addressing Attention-Deficit/Hyperactivity Disorder in the workplace.
1211 – ADD-H-Comprehensive Teacher’s Rating Scale (ACTeRS): A Measure for Attention Deficit Hyperactivity Disorder Among Children with Intellectual Disability in India.
1210 – Abnormal Functional Resting-State Networks in ADHD: Graph Theory and Pattern Recognition Analysis of fMRI Data.
1209 – A randomised controlled trial of combined EEG feedback and methylphenidate therapy for the treatment of ADHD
1208 – A Comparison of Mindfulness-Based Group Training and Skills Group Training in Adults With ADHD – An Open Study
1206 – Sex differences in ADHD symptom severity.
1205 – Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)
1204 – Rates of Effort Test Failure in Children With ADHD: An Exploratory Study.
1203 – Neurocognitive abilities in the general population and composite genetic risk scores for attention-deficit hyperactivity disorder.
1202 – Nationwide rate of attention-deficit hyperactivity disorder diagnosis and pharmacotherapy in Korea in 2008–2011
1201 – Increasing Phenotypic and Genetic variations in Hyperactivity/Inattention Problems from Age 3 to 13 Years: A Cross-Sectional Twin Study.
1200 – Impact of attention-deficit/hyperactivity disorder on the lives of Italian children and adolescents: data from the European Lifetime Impairment Survey.
1199 – Geographic Variation in Receipt of Psychotherapy in Children Receiving Attention-Deficit/Hyperactivity Disorder Medications
1198 – Functional status in children with ADHD at age 6-8: a controlled community study.
1197 – Factors Related to Self-Reported Attention Deficit Among Incoming University Students
1196 – Examination of the Effects of Intelligence on the Test of Variables of Attention for Elementary Students
1195 – Environmental Lead Exposure and Attention-Deficit/Hyperactivity Disorder Symptom Domains in a Community Sample of South Korean School-Age Children.
1194 – Effect of Play Therapy on Visual Memory in ADHD Children
1193 – Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).
1192 – Dose Response Effects of Quillivant XR
1191 – Contrasting psychosocial outcomes in Chinese delinquent adolescents with attention deficit and hyperactivity disorder symptoms and/or reading disability
1189 – Brain abnormalities in attention-deficit hyperactivity disorder: a review.
1188 – Brief Experimental Analysis of Reading Deficits for Children With Attention-Deficit/Hyperactivity Disorder.
1187 – Cyberbullying among male adolescents with attention-deficit/hyperactivity disorder: Prevalence, correlates, and association with poor mental health status.
1186 – Differential associations of early callous-unemotional, oppositional, and ADHD behaviors: multiple domains within early-starting conduct problems?
1185 – Discipline styles and co-morbid disorders of adolescents with attention deficit hyperactivity disorder: a longitudinal study.
1184 – Distinct Patterns of Everyday Executive Function Problems Distinguish Children With Tourette Syndrome From Children With ADHD or Autism Spectrum Disorders
1183 – DRD4 VNTRs, observed stranger fear in preschoolers and later ADHD symptoms
1182 – Drug Holidays From ADHD Medication International Experience Over the Past Four Decades
1181 – Effect of Cognitive Intervention on Children with ADHD.
1180 – Effects of the combination of wheel running and atomoxetine on cue- and cocaine-primed reinstatement in rats selected for high or low impulsivity.
1179 – Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient’s perspective.
1178 – Examination of the Role of Expectancies on Task Performance in College Students Concerned about ADHD.
1177 – Examining the Role of Callous-Unemotional Traits in the Attributional Styles and Self Competence Evaluations of Children with Conduct Problems and ADHD
1176 – Genetic factors underlying attention and impulsivity: mouse models of attention-deficit/hyperactivity disorder
1175 – Inattention symptoms and the diagnosis of comorbid attention-deficit/hyperactivity disorder among youth with generalized anxiety disorder.
1174 – Intergenerational transmission of fronto-parietal dysfunction during forethought in attention deficit/hyperactivity disorder: A pilot study
1173 – Internal consistency and concurrent validity of questionnaire for assessment of limitations and restrictions in children with ADHD.
1172 – Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
1171 – Is age a better predictor of weight loss one year after gastric bypass than symptoms of disordered eating, depression, adult ADHD and alcohol consumption?
1170 – Masculinization in Parents of Offspring With Autism Spectrum Disorders Could Be Involved in Comorbid ADHD Symptoms
1169 – Maternal Anxiety and Attention Deficit Hyperactivity Disorder (ADHD) in Children
1168 – Measuring Executive Function in the Differential Diagnosis of Attention-Deficit/Hyperactivity Disorder: Does It Really Tell Us Anything?
1167 – Methylphenidate Ameliorates Depressive Comorbidity in ADHD Children without any Modification on Differences in Serum Melatonin Concentration between ADHD Subtypes.
1166 – Neuropsychological Heterogeneity in Preschool ADHD: Investigating the Interplay between Cognitive, Affective and Motivation-Based Forms of Regulation.
1165 – Neurotrophic factors and their importance in attention deficit hyperactivity disorder.
1164 – Orality and writing: argumentation in children with attention deficit hyperactivity disorder.
1163 – Passive tactile stimulation and its clinical and neurophysiological repercussions (P300) in blind children with symptoms of attention deficit disorder.
1162 – Pharmacological management of attention deficit hyperactivity disorder with methylphenidate and atomoxetine within a context of epilepsy.
1161 – Predicting methylphenidate response in attention deficit hyperactivity disorder: A preliminary study.
1160 – Relationships Between Computer-Based Testing and Behavioral Ratings in the Assessment of Attention and Activity in a Pediatric ADHD Stimulant Crossover Trial.
1159 – Services for young people with attention deficit/hyperactivity disorder transitioning from child to adult mental health services: A national survey of mental health trusts in England.
1158 – Sleep and cognitive problems in patients with attention-deficit hyperactivity disorder.
1157 – Sleepiness, Sleep Disorders and Attention-Deficit/Hyperactivity Disorder: Pathophysiological Rationale and Future Perspectives
1156 – Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children (ECOMEGA)
1155 – The behavioural response of mice lacking NK1 receptors to guanfacine resembles its clinical profile in treatment of ADHD
1154 – The effect of alpha-linolenic acid supplementation on ADHD symptoms in children: a randomized controlled double-blind study
1153 – The P300 component as a neurophysiological correlate of behavioural working memory in adolescents with attention deficit hyperactivity disorder.
1152 – The path from childhood behavioural disorders to felony offending: Investigating the role of adolescent drinking, peer marginalisation and school failure.
1150 – The relations between attention deficit and hyperactivity disorder and different types of headaches in a non- clinical sample of adolescents
1149 – Theta/beta ratio (NEBA) in the diagnosis of attention deficit hyperactivity disorder.
1148 – Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
1147 – Use of EEG to diagnose ADHD.
1146 – Utility of the Test of Memory Malingering (TOMM) in Children Ages 4-7 Years with and without ADHD.
1145 – White Matter Microstructure and The Variable Adult Outcome of Childhood Attention Deficit Hyperactivity Disorder.
1144 – ADD-H-Comprehensive Teacher’s Rating Scale (ACTeRS): A Measure for Attention Deficit Hyperactivity Disorder Among Children with Intellectual Disability in India.
1143 – Caudate asymmetry is related to attentional impulsivity and an objective measure of ADHD-like attentional problems in healthy adults.
1077 – Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review
1054 – B-78Relationship between ADHD Symptoms and Vermis Activation Using Single-Photon Emission Computed Tomography (SPECT).
1021 – Prevalence, Gender Distribution and Presence of Attention Deficit Hyperactivity Disorder by Certain Sociodemographic Characteristics Among University Students
972 – EPA-0682 – Investigator-rated symptomatological outcomes in a phase 4 study of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder and impaired executive function
969 – EPA-0685 – Guanfacine XR (GXR) for children and adolescents with attention-deficit/hyperactivity disorder (ADHD): phase 3, randomized, double-blind, multicenter, placebo- and active-reference study
965 – EPA-0666 – Long-term maintenance of efficacy of extended-release guanfacine hydrochloride (GXR) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): double-blind, placebo-controlled, multicentre, phase 3 randomized withdrawal study
957 – EPA-0775 – Efficacy of lisdexamfetamine dimesylate and atomoxetine in child and adolescent subgroups from a head-tohead, double-blind, randomized trial in patients with attention-deficit/hyperactivity disorder
902 – The effectiveness of meta-cognitive knowledge on reduced hyperactivity and improved attention in children afflicted with attention deficit and hyperactivity disorder (ADHD) in the primary school
875 – Knowledge and misperceptions towards diagnosis and management of attention deficit hyperactive disorder (ADHD) among primary school and kindergarten female teachers in Al-Rusaifah district, Makkah City, Saudi Arabia.
870 – Further evidence that severe scores in the aggression/anxiety-depression/attention subscales of child behavior checklist (severe dysregulation profile) can screen for bipolar disorder symptomatology: a conditional probability analysis.
862 – Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): A randomized placebo-controlled intervention trial
853 – Comparative Mortality Risk in Adult Patients With Schizophrenia, Depression, Bipolar Disorder, Anxiety Disorders, and Attention-Deficit/Hyperactivity Disorder Participating in sychopharmacology Clinical Trials
Outros artigos científicos: